BALAXI PHARMACEUTICALS
Back to Income Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-7.31 Cr | ₹52 Cr | ₹48 Cr | ₹37 Cr | ₹6.13 Cr |
What is the latest Consolidated Net Profit of BALAXI PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-7.31 Cr |
| Mar2024 | ₹52 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹37 Cr |
| Mar2021 | ₹6.13 Cr |
How is Consolidated Net Profit of BALAXI PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-7.31 Cr | Negative | |
| Mar2024 | ₹52 Cr | 7.39 | |
| Mar2023 | ₹48 Cr | 29.41 | |
| Mar2022 | ₹37 Cr | 507.51 | |
| Mar2021 | ₹6.13 Cr | - | |
Compare Consolidated Net Profit of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹97.9 Cr | -1.6% | -12.7% | -74% | Stock Analytics | |
| ADANI ENTERPRISES | ₹243,806.0 Cr | -2.6% | -13.8% | -19.8% | Stock Analytics | |
| REDINGTON | ₹16,511.1 Cr | -3.7% | -14% | -7.7% | Stock Analytics | |
| HONASA CONSUMER | ₹9,564.3 Cr | 6.1% | -4.2% | 29.8% | Stock Analytics | |
| MMTC | ₹8,544.0 Cr | -5.7% | -7.4% | 5.4% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹6,784.0 Cr | -2.2% | -16.7% | 9.6% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -1.6% |
-12.7% |
-74% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses